Wolverine Asset Management’s BridgeBio Pharma BBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Sell	14,900 -34,500	-70%	-$2.5M	0.01%	749
2025 Q4	$3.78M	Hold	49,400	–	–	0.03%	418
2025 Q3	$2.57M	Buy	49,400 +14,500	+42%	+$707K	0.02%	501
2025 Q2	$1.51M	Buy	34,900 +400	+1%	+$14.5K	0.01%	591
2025 Q1	$1.19M	Sell	34,500 -3,600	-9%	-$121K	0.01%	630
2024 Q4	$1.05M	Sell	38,100 -25,000	-40%	-$646K	0.01%	685
2024 Q3	$1.61M	Buy	63,100 +25,000	+66%	+$656K	0.02%	568
2024 Q2	$965K	Hold	38,100	–	–	0.01%	680
2024 Q1	$1.18M	Hold	38,100	–	–	0.01%	607
2023 Q4	$1.54M	Buy	+38,100	New	+$1.14M	0.01%	591
2022 Q1	–	Sell	-1,000	Closed	-$16K	–	2161
2021 Q4	$16K	Sell	1,000 -175,200	-99%	-$7.41M	﹤0.01%	1766
2021 Q3	$8.26M	Buy	176,200 +1,000	+0.6%	+$53.6K	0.07%	225
2021 Q2	$10.7M	Buy	175,200 +70,000	+67%	+$4M	0.08%	199
2021 Q1	$6.48M	Buy	105,200 +25,200	+32%	+$1.65M	0.05%	212
2020 Q4	$5.69M	Buy	+80,000	New	+$3.86M	0.04%	243